4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since Jan. 12.

Advertisement

1. Firvanq is a vancomycin hydrochloride oral solution used to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation.

2. Lutathera is a radioactive drug that treats gastroenteropancreatic neuroendocrine tumors.

3. Bivalirudin is an anticoagulant intended for patients undergoing percutaneous coronary intervention.

4. Avycaz may now be used to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

More articles on supply chain:
10 most-read supply chain stories in January
Hospitals face shortage of sterile water for injections: 5 things to know
FDA approves record number of personalized medicines in 2017: 4 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.